Health Care [ 5/12 ] | Health Care Equipment & Supplies [ 31/74 ]
NASDAQ | Common Stock
Aclarion, Inc. operates as a healthcare technology company in the United States.
The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments.
It develops NOCISCAN software application, a non-invasively analyze the chemical makeup of intervertebral discs in the spine.
The company also develops NOCISCAN Post-Processor Suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software.
The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021.
Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.
Reported date | EPSChange YoY | EstimateSurprise |
---|---|---|
Nov 27, 24 | -50.25 Decreased by -42.85 K% | -60.30 Increased by +16.67% |
Aug 23, 24 | -50.25 Decreased by -33.40 K% | -77.05 Increased by +34.78% |
May 15, 24 | -0.44 Decreased by -340.00% | -0.57 Increased by +22.81% |
Feb 20, 24 | -1.53 Decreased by -801.71% | -1.60 Increased by +4.19% |
Nov 14, 23 | -0.12 Increased by +44.29% | -0.09 Decreased by -30.00% |
Jul 3, 23 | -0.15 Increased by +69.39% | -0.10 Decreased by -50.00% |
May 31, 23 | -0.10 Increased by +92.59% | -0.10 |
Mar 1, 23 | -0.17 | -0.17 |
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Sep 30, 24 | 14.41 K Decreased by -24.43% | -1.37 M Decreased by -36.89% | Decreased by -9.48 K% Decreased by -81.15% |
Jun 30, 24 | 10.97 K Decreased by -56.93% | -1.24 M Decreased by -4.30% | Decreased by -11.28 K% Decreased by -142.14% |
Mar 31, 24 | 10.11 K Decreased by -60.29% | -2.40 M Decreased by -102.72% | Decreased by -23.72 K% Decreased by -410.51% |
Dec 31, 23 | 13.80 K Decreased by -38.73% | -1.27 M Increased by +4.88% | Decreased by -9.17 K% Decreased by -55.26% |
Sep 30, 23 | 19.07 K Increased by +4.63% | -998.01 K Increased by +38.88% | Decreased by -5.23 K% Increased by +41.58% |
Jun 30, 23 | 25.47 K Increased by +138.57% | -1.19 M Increased by +67.98% | Decreased by -4.66 K% Increased by +86.58% |
Mar 31, 23 | 25.47 K Increased by +182.18% | -1.18 M Decreased by -7.68% | Decreased by -4.65 K% Increased by +61.84% |
Dec 31, 22 | 22.52 K Increased by +88.03% | -1.33 M Increased by +57.59% | Decreased by -5.91 K% Increased by +77.44% |